Vehicle transporting meat torched in Belagavi

Bengaluru, Feb 10: A group of women on Monday started a protest against Citizenship Amendment Act (CAA), National Register of Citizens (NRC), and National Population Register (NPR) here near Bilal Masjid.

Members of the transgender community on Sunday had also taken out a march here to express solidarity with those protesting against CAA, NRC, and NPR.

The newly enacted law is facing stiff opposition across the country with some states including Kerala, West Bengal, Rajasthan and Punjab refusing to implement it. Rajasthan, Kerala, and Punjab have also passed resolutions against the amended citizenship law in their legislative Assemblies.

The CAA grants citizenship to Hindu, Sikh, Jain, Parsi, Buddhist, and Christian refugees from Pakistan, Afghanistan, and Bangladesh, who came to India on or before December 31, 2014.

Mangaluru, Apr 29: One person was arrested on charges of murdering a middle-aged couple on Wednesday in Yellinje near Kinnigoli.

The area falls under the jurisdiction of Mulky police.

Police said that the deceased were identified as Vincent D’Souza (50) and his wife Helina D’ Souza (45).

The arrested was identified as Alphonso (55). He will be sent to judicial custody, said police.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.